BSE Live
Feb 05, 16:01Prev. Close
396.10
Open Price
401.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 05, 15:57Prev. Close
397.00
Open Price
395.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
400.20 (35)
| Profit & Loss account of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 680.71 | 567.88 | 517.20 | 581.54 | 489.08 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 680.71 | 567.88 | 517.20 | 581.54 | 489.08 | |
| Total Operating Revenues | 687.35 | 571.88 | 526.67 | 588.86 | 494.62 | |
| Other Income | 14.83 | 9.37 | 8.42 | 29.25 | 12.43 | |
| Total Revenue | 702.18 | 581.25 | 535.09 | 618.11 | 507.05 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 188.27 | 164.51 | 156.92 | 166.25 | 162.53 | |
| Purchase Of Stock-In Trade | 2.00 | 2.47 | 6.11 | 4.32 | 1.09 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | 0.81 | -0.28 | 0.20 | -0.88 | 0.28 | |
| Employee Benefit Expenses | 126.77 | 107.86 | 106.15 | 61.13 | 58.07 | |
| Finance Costs | 3.05 | 4.20 | 2.35 | 2.37 | 0.87 | |
| Depreciation And Amortisation Expenses | 55.26 | 47.01 | 38.71 | 33.87 | 30.28 | |
| Other Expenses | 179.14 | 159.89 | 137.24 | 123.15 | 101.39 | |
| Total Expenses | 555.30 | 485.66 | 447.68 | 390.21 | 354.51 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 146.88 | 95.59 | 87.41 | 227.90 | 152.54 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 146.88 | 95.59 | 87.41 | 227.90 | 152.54 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 47.82 | 30.12 | 30.16 | 56.21 | 44.25 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 6.87 | -3.63 | -5.93 | -4.63 | -4.93 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 54.69 | 26.49 | 24.23 | 51.58 | 39.32 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 92.19 | 69.10 | 63.18 | 176.32 | 113.22 | |
| Profit/Loss From Continuing Operations | 92.19 | 69.10 | 63.18 | 176.32 | 113.22 | |
| Profit/Loss For The Period | 92.19 | 69.10 | 63.18 | 176.32 | 113.22 | |
| Minority Interest | 0.76 | 1.27 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 91.51 | 70.76 | 64.36 | 176.14 | 113.15 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 17.00 | 13.00 | 12.00 | 33.00 | 21.00 | |
| Diluted EPS (Rs.) | 17.00 | 13.00 | 12.00 | 33.00 | 21.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 95.31 | 95.27 | 79.35 | 79.31 | 52.84 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
29.01.2026
Thyrocare Techn Consolidated December 2025 Net Sales at Rs 195.53 crore, up 17.85% Y-o-Y
29.01.2026
Thyrocare Techn Standalone December 2025 Net Sales at Rs 182.48 crore, up 19.62% Y-o-Y
29.01.2026
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
29.01.2026
Thyrocare Techn Consolidated December 2025 Net Sales at Rs 195.53 crore, up 17.85% Y-o-Y
29.01.2026
Thyrocare Techn Standalone December 2025 Net Sales at Rs 182.48 crore, up 19.62% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss